MCC's Dr. Carol Lange, a dedicated researcher in breast cancer, shares her personal journey with cancer. Her experience illustrates not only the vital role of cancer research but also the profound impact of participating in clinical trials. Read her story here: https://lnkd.in/gQn9jFbY
Masonic Cancer Center, University of Minnesota
医院和医疗保健
Minneapolis，Minnesota 2,310 位关注者
The Twin Cities' only NCI-designated comprehensive cancer center. #UMNCancer
关于我们
The Masonic Cancer Center, University of Minnesota is the Twin Cities’ own Comprehensive Cancer Center, designated ‘Outstanding’ by the National Cancer Institute. For 30 years, our researchers, educators and care providers have worked to discover the causes, prevention, detection, and treatment of cancer and cancer-related diseases. Learn more at cancer.umn.edu. As one of only 51 National Cancer Institute-designated Comprehensive Cancer Centers in the U.S., we are recognized for dedication to the highest standards of cancer research, patient care, education, and community outreach. We are part of the Big Ten Cancer Research Consortium, a network of academic institutions working together on highly translational clinical trials using the expertise of Big Ten universities. Adding to the depth and breath of research are the Masonic Cancer Center's UMN research partners including the Medical School, School of Dentistry, School of Nursing, College of Pharmacy, School of Public Health, College of Veterinary Medicine, Stem Cell Institute, Center for Immunology, and the Center for Magnetic Resonance Imaging. The center's clinical research and treatment partners include University of Minnesota Health - Cancer Care, University of Minnesota Medical Center, and University of Minnesota Masonic Children's Hospital. Research areas of excellence: -Tobacco research -Cell therapy for hematologic malignancies -Biomarkers to understand the mechanisms of carcinogenesis -Innovative methods to identify and understand cancer genes -Childhood cancer -Immunotherapy -Functional genomics -Cancer prevention and control -Epidemiological research We also lead the Minnesota Cancer Clinical Trials Network (MNCCTN).
- 网站
-
https://cancer.umn.edu/index.htm
Masonic Cancer Center, University of Minnesota的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 501-1,000 人
- 总部
- Minneapolis，Minnesota
- 类型
- 非营利机构
- 创立
- 1991
- 领域
- Cancer Research、Carcinogenesis、Cancer Education、Chemoprevention、Bone Marrow Transplant、Immunotherapy for Cancer Treatment、Gene Therapy for Cancer Treatment、Clinical Trials Initiation and Management、Translational Cancer Research、cancer prevention、cancer survivorship、metastatic breast cancer、brain tumor research、head and neck cancers、sarcoma、gynecologic oncology、bone marrow transplant (BMT)和cancer community education
地点
-
主要
获取路线
Masonic Cancer Center, University of Minnesota
420 Delaware Street SE, Mayo Mail Code 806
US，Minnesota，Minneapolis，55455
Masonic Cancer Center, University of Minnesota员工
-
Gretchen Sieger
Director of Operations, Clinical Informatics - Clinical and Translational Science Institute at University of Minnesota
-
Laura Klein
Research Development Manager
-
Andrea Johnson, MBA
Finance Director at Masonic Cancer Center, University of Minnesota
-
Gretchen Unger
Chief Scientific Officer at Surtovol Laboratories
动态
-
Encouraging to see this news from KARE 11's Boyd Huppert after receiving treatment from MCC doctors! Our scientists and doctors are tirelessly working to advance treatments like this, aiming to create even more success stories in the future. Read more about Boyd's story: https://ow.ly/J1zf50Ug3wF.
-
MCC's Director, Douglas Yee, MD, is quoted in this story about a 39 year old Minnesota woman who was inspired by her breast cancer diagnosis to spread awareness to younger women and the Latino community. Read the full article here: https://lnkd.in/g6YeHS8c
Yuen: Breast cancer in young women is on the rise. One survivor is talking about it – and all things ‘Tetas.’
startribune.com
-
Register now for the Fireside Chat on December 11th with MCC's Office of Community Outreach and Engagement and Dr. Brandon Moriarity as they discuss advances in genome engineering and its potential role in cancer treatment. Find the details here: https://lnkd.in/eVBp4BPR
-
-
Exciting news in cervical cancer screening! ?? Scientists, like MCC's Dr. Rebekah Pratt, have been working on a new self-collect option that could revolutionize cervical cancer screening access, making it easier for more people to get tested. Read more: https://lnkd.in/g7aRpqJp
-
-
TODAY at 1 p.m. we're talking all things lung cancer with MCC's Dr. Abbie Begnaud and Dan Tranter. We'll be covering key aspects of lung cancer, including risk factors, prevention, diagnosis, and treatment. There's still time to register: https://lnkd.in/eVBp4BPR
-
-
Tomorrow, MCC's Dr. Abbie Begnaud and Dan Tranter will join us for a Fireside Chat about lung cancer. We'll be covering key aspects of lung cancer, including risk factors, prevention, diagnosis, and treatment. RSVP today: https://lnkd.in/eVBp4BPR.
-
-
Among the many factors at play in overcoming cancer care gaps in the U.S., increased screening and access to care are top of mind. Clinical trial participation is also crucial. Find out how we are addressing this in the North Star State via The Minnesota Cancer Clinical Trials Network: https://ow.ly/L2NS50U8gyU
Meet the group making cancer trials more equitable in Minnesota
beckershospitalreview.com
-
November is Lung Cancer Awareness Month. This month we sat down with Dr. Abbie Begnaud and Dan Tranter, to chat about all things lung cancer. Read the full article: https://lnkd.in/gHQGWH_W Dr. Begnaud and Dan will also be the special expert guests at our Fireside Chat on November 20!
-
-
There's still time to reserve your spot at the upcoming Fireside Chat on November 20th with MCC's Office of Community Outreach and Engagement, Dr. Abbie Begnaud, and Dan Tranter as they discuss the key risk factors, prevention, and screening for lung cancer. Find the details here: https://lnkd.in/eVBp4BPR
-